Recurrent osteosarcoma with a single pulmonary metastasis: a multi-institutional review
Open Access
- 25 November 2014
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 112 (2), 278-282
- https://doi.org/10.1038/bjc.2014.585
Abstract
Late relapse and solitary lesion are positive prognostic factors in recurrent osteosarcoma. We reviewed the records of 39 patients treated at three major centres for recurrent osteosarcoma with a single pulmonary metastasis more than 1 year after diagnosis. We analysed their outcomes with respect to clinical factors and treatment with chemotherapy. Median age at diagnosis was 14.6 years. Relapse occurred at a median of 2.5 years (range, 1.2–8.2 years) after initial diagnosis. At relapse, all patients were treated by metastasectomy; 12 (31%) patients also received chemotherapy. There was no difference in time to recurrence or nodule size between the patients who received or did not receive chemotherapy at relapse. Sixteen patients had no subsequent recurrence, 13 of whom survive without evidence of disease. The 5-year and 10-year estimates of post-relapse event-free survival (PREFS) were 33.0±7.5% and 33.0±9.6%, respectively, and of post-relapse survival (PRS) 56.8±8.6% and 53.0±11.0%, respectively. There was a trend for nodules <1.5 cm to correlate positively with PREFS (P=0.070) but not PRS (P=0.49). Chemotherapy at first relapse was not associated with PREFS or PRS. Approximately half of the patients with recurrent osteosarcoma presenting as a single pulmonary metastasis more than 1 year after diagnosis were long-term survivors. Metastasectomy was the primary treatment; chemotherapy did not add benefit.Keywords
This publication has 22 references indexed in Scilit:
- Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trialsAnnals of Oncology, 2012
- Patients with osteosarcoma with a single pulmonary nodule on computed tomography: a single-institution experienceJournal of Pediatric Surgery, 2012
- Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcomaJournal of Pediatric Surgery, 2006
- Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, ItalyEuropean Journal of Cancer, 2005
- Resection of recurrent pulmonary metastases in patients with osteosarcomaCancer, 2005
- Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institutionEuropean Journal of Cancer, 2005
- Survival after recurrence of osteosarcoma: A 20‐year experience at a single institutionPediatric Blood & Cancer, 2005
- Treatment and outcome of recurrent osteosarcoma: Experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapyActa Oncologica, 2005
- Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapyCancer, 2003
- The patterns of relapse in osteosarcoma: The memorial Sloan-Kettering experiencePediatric Blood & Cancer, 2003